The medical nutrition market size is estimated at USD 14.69 Bn in 2025 and is expected to reach USD 21.53 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
Market Overview
The medical nutrition market is expected to keep growing steadily in the coming years. This growth is driven by a greater understanding of how nutrition impacts health and rise in new product introductions.
The growing elderly population, who are more prone to long-term illnesses, will increase the need for nutritional assistance and specialised medical nutrition products. The market is also seeing demand for products that are designed for particular health issues and diseases, which is anticipated to be a trend.
To learn more about this report, Download Free Sample
To learn more about this report, Download Free Sample
|
Current Events |
Description and its impact |
|
Global Economic Volatility & Inflationary Pressure
|
|
|
Advances in Technology & Innovation in Nutritional Science |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The medical nutrition market is focused on creating tailored products to meet the specific needs of customers. Advanced technology and diagnostic tools allow for more customised approaches. Companies like InsideTracker are using smart computer systems to provide specific dietary and supplement recommendations, in order to improve health outcomes.
Medical nutrition products play a crucial role in patient care, especially among populations with specialized nutritional needs, chronic illnesses, and those who need therapeutic nutritional support.
Manufacturers are engaged in the development and launch of innovative and novel medical nutrition products, which is expected to drive the growth of the global medical nutrition market.
On January 25, 2023, Nutricia, a subsidiary of Danone, a multinational food-products corporation, announced the launch of Fortimel, which is meant to meet the dietary needs of malnourished patients and those at risk of becoming malnourished.
The prevalence of chronic diseases has been steadily increasing over the past few decades. Chronic diseases such as diabetes, cancer, digestive disorders etc., have become quite common. For instance, according to a report published in Center for disease control and prevention on October 14, 2022, around 697,000 people in the U.S. died from heart disease in 2020, whereas around 20.1 million adults aged 20 and older had Coronary Artery Disease (CAD) in the U.S. in 2020.
A major reason for this rise is the changing lifestyle and dietary habits of people. People are consuming more processed and fried foods which are high in fat, salt, and sugar. This changing disease profile has increased the demand for specialized medical nutrition products.
Market players are focused on entering potential untapped markets in emerging economies such as India and China, where the prevalence of nutritional deficiency is high.
In terms of Nutrition type, proteins subsegment is expected to have 30.8% of the market share in 2025 owing to the increasing awareness about the importance of essential nutrients for daily functioning.
Proteins are one of the most crucial macronutrients required by the body to build muscles, organs, skin, and blood. They also help in transporting nutrients, regulating body processes, and strengthening immunity.
Furthermore, protein requirements are heightened for patients suffering from chronic diseases, elderly population, and athletes. Hence, the protein segment dominates the medical nutrition market.
In terms of indication, the diabetes subsegment is expected to have 35.8% of the market share in 2025 due to the growing prevalence of the disease and the need for personalized care plans.
Diabetes has become one of the most common lifestyle disorders affecting people globally. Medical nutrition therapy plays a pivotal role in effective diabetes management by controlling blood sugar levels and moderating energy intake.
In terms of end user, the hospitals subsegment is expected to have 38.7% of the market share in 2025 owing to the centralization of healthcare services.
Hospitals are increasingly acknowledging the importance of clinical nutrition in patient care, many are establishing dedicated nutrition support teams and specialized departments. This expanding role has elevated the demand for therapeutic nutrition from hospitals.
To learn more about this report, Download Free Sample
North America remains the dominant region and is anticipated to hold 39.3% of the market share in 2025. The presence of leading global players and established healthcare infrastructure have propelled market development.
The U.S. accounts for the major share due to high healthcare spending and awareness levels among consumers regarding nutritional interventions for clinical conditions. Several initiatives by regulatory authorities to enhance quality standards along with private-public partnerships for innovation in formulations have strengthened the market position.
The Asia Pacific region is poised to exhibit the highest growth fueled by increasing healthcare expenditures, growing middle-class population, and awareness regarding prevention through nutrition. China and India represent the hotspots owing to rising instances of metabolic disorders and expanding medical coverage in rural areas.
Fresenius Kabi has been expanding its parenteral nutrition portfolio in China, targeting hospital nutrition markets and establishing partnerships with local healthcare providers. Healthcare reforms focusing on malnutrition and integration of traditional expertise with evidence-based guidelines are aiding growth.
The U.S. medical nutrition market has seen approximately 8% growth in 2024. The medical nutrition industry in the U.S. is growing due to factors like more chronic diseases and a larger elderly population. Rising consumer demand for plant-based and sustainable medical nutrition products is emerging as a key market trend.
The business for special foods in India is growing owing to elderly population and adults with long-term sicknesses. Companies like Danone focus on developing affordable medical nutrition solutions suited to the Indian market, recognizing the price sensitivity of many consumers.
India has significantly expanded its domestic manufacturing capacity, leading to a 25% reduction in import dependence since 2023. Multinational companies such as Nestlé Health Science, Abbott, and Danone continue market dominance but facing increased competition from domestic players like Cipla Nutrition, Emcure Nutrition, and Zydus Wellness.
Medical Nutrition Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 14.69 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.6% | 2032 Value Projection: | USD 21.53 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbott, Danone S.A., Baxter, Nestlé, GSK plc., Sun Pharmaceutical Industries Ltd., Sanofi, DSM, BASF SE, Fresenius SE & Co. KGaA, Leprino Foods Company, Fresenius Kabi Ltd, Esperer Onco Nutrition, Kate Farms, and Guardion Health Sciences, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Magazines:
*Definition: The medical nutrition market includes products like supplemental nutrition, food for special medical purposes, and clinical nutrition. These are specially formulated nutritional products used in the clinical management and treatment of patients suffering from chronic diseases or health conditions like diabetes, cancer, malnutrition, gastrointestinal disorders, pulmonary diseases, and others. Medical nutrition helps meet the specialized nutritional needs of patients through the use of supplements, enteral feeding, and parenteral nutrition.
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
